Satellos Bioscience Inc. (MSCLF)
USD 0.48
(-4.42%)
USD 0.48
(-4.42%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -15.88 Million CAD | -40.33% |
| 2022 | -11.32 Million CAD | 26.98% |
| 2021 | -15.5 Million CAD | -882.28% |
| 2020 | -1.57 Million CAD | 18.56% |
| 2019 | -1.93 Million CAD | -13.84% |
| 2018 | -1.7 Million CAD | -37.61% |
| 2017 | -1.23 Million CAD | 16.95% |
| 2016 | -1.48 Million CAD | 16.99% |
| 2015 | -1.79 Million CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -6.9 Million CAD | -5.72% |
| 2024 Q2 | -6.03 Million CAD | 12.64% |
| 2023 Q2 | 4.11 Million CAD | 347.07% |
| 2023 FY | -15.88 Million CAD | -40.33% |
| 2023 Q3 | -3.57 Million CAD | -186.85% |
| 2023 Q1 | -1.66 Million CAD | 67.16% |
| 2023 Q4 | -6.53 Million CAD | -82.85% |
| 2022 Q1 | -2.11 Million CAD | 16.29% |
| 2022 FY | -11.32 Million CAD | 26.98% |
| 2022 Q4 | -5.07 Million CAD | -167.15% |
| 2022 Q3 | -1.89 Million CAD | 15.11% |
| 2022 Q2 | -2.23 Million CAD | -5.7% |
| 2021 Q3 | -11.25 Million CAD | -2105.71% |
| 2021 Q1 | -861.8 Thousand CAD | -101.4% |
| 2021 Q2 | -510.3 Thousand CAD | 40.79% |
| 2021 FY | -15.5 Million CAD | -882.28% |
| 2021 Q4 | -2.52 Million CAD | 77.55% |
| 2020 Q4 | -427.9 Thousand CAD | -50.17% |
| 2020 Q3 | -284.94 Thousand CAD | 10.7% |
| 2020 Q2 | -319.09 Thousand CAD | 50.02% |
| 2020 Q1 | -638.38 Thousand CAD | 0.0% |
| 2020 FY | -1.57 Million CAD | 18.56% |
| 2019 FY | -1.93 Million CAD | -13.84% |
| 2018 FY | -1.7 Million CAD | -37.61% |
| 2017 FY | -1.23 Million CAD | 16.95% |
| 2016 FY | -1.48 Million CAD | 16.99% |
| 2015 FY | -1.79 Million CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Evofem Biosciences, Inc. | 52.97 Million USD | 129.991% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -127.544% |
| CSL Limited | 2.64 Billion USD | 100.601% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 124.395% |
| Regen BioPharma, Inc. | 1.02 Million USD | 1652.406% |
| BioStem Technologies, Inc. | -8.48 Million USD | -87.304% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -316.051% |
| Qrons Inc. | -789.34 Thousand USD | -1912.93% |
| Nascent Biotech, Inc. | -2.08 Million USD | -661.083% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 74.618% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -101.048% |
| Skye Bioscience, Inc. | -37.64 Million USD | 57.792% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -3724.261% |
| Rebus Holdings, Inc. | -1.02 Million USD | -1457.745% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | -0.111% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -1089.803% |
| Genscript Biotech Corporation | -95.47 Million USD | 83.358% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -2412.464% |
| Adynxx, Inc. | - USD | Infinity% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 78.804% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -141.617% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -5711.589% |
| SQZ Biotechnologies Company | -79.46 Million USD | 80.005% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -449.337% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -772.769% |
| Mesoblast Limited | -87.95 Million USD | 81.935% |
| Marizyme, Inc. | -65.34 Million USD | 75.685% |
| Genus plc | 7.9 Million USD | 301.127% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | -45.881% |
| Pharming Group N.V. | -10.54 Million USD | -50.635% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -632.275% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -328.248% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -79.659% |
| ContraFect Corporation | -65.15 Million USD | 75.613% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -225.19% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -819.792% |
| IMV Inc. | -36.48 Million USD | 56.451% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -97.142% |
| MultiCell Technologies, Inc. | -380.07 USD | -4180445.689% |
| ONE Bio Corp. | 8.67 Million USD | 283.124% |
| Accustem Sciences Inc. | -3.74 Million USD | -324.112% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 69.262% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | -1153.932% |
| Q BioMed Inc. | -2.05 Million USD | -674.283% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -325.636% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -567.361% |
| Biomind Labs Inc. | -1.21 Million USD | -1208.47% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 73.397% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -412.256% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -715.134% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -105996.421% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -173.136% |
| GB Sciences, Inc. | -1.36 Million USD | -1066.87% |
| Alpha Cognition Inc. | -13.77 Million USD | -15.367% |
| HST Global, Inc. | -146.21 Thousand USD | -10767.246% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -805.474% |
| Halberd Corporation | -79.67 Thousand USD | -19842.015% |
| Enzolytics Inc. | -2.17 Million USD | -629.914% |
| Agentix Corp. | -1.37 Million USD | -1056.227% |
| Resverlogix Corp. | -3.61 Million USD | -340.139% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -401.003% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 94.615% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 16313.265% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 329.457% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -299.925% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -425.059% |
| AVAX Technologies, Inc. | -6.41 Million USD | -147.737% |
| Zenith Capital Corp. | -10.59 Million USD | -49.953% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -68263.308% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -283.243% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -26188.616% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -692.423% |
| Kadimastem Ltd | -3.3 Million USD | -380.408% |
| Helix BioMedix, Inc. | -1.05 Million USD | -1404.559% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -3499.936% |
| LadRx Corporation | 400.44 Thousand USD | 4067.856% |
| Cell Source, Inc. | -5.32 Million USD | -198.597% |
| Regen BioPharma, Inc. | 1.02 Million USD | 1652.406% |
| NovAccess Global Inc. | -4.76 Million USD | -233.16% |
| Affymax, Inc. | -14.42 Million USD | -10.157% |
| Itoco Inc. | -1.86 Million USD | -750.136% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -257.656% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -852.007% |
| Mobile Lads Corp. | -2.26 Million USD | -602.03% |
| CytoDyn Inc. | -49.84 Million USD | 68.121% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -20004.26% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -6864.98% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -1587.574% |
| SYBLEU INC | -180.3 Thousand USD | -8712.339% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -885.22% |
| International Stem Cell Corporation | -131 Thousand USD | -12029.008% |
| Bioxytran, Inc. | -4.28 Million USD | -271.238% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -29176.607% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -527.962% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 66.947% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -651.608% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -1934.737% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -401.547% |
| Neutra Corp. | -233.46 Thousand USD | -6705.731% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 21.694% |
| PureTech Health plc | -65.69 Million USD | 75.815% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | 25.286% |
| IXICO plc | -1.17 Million USD | -1248.812% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -60.058% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 72.187% |
| CSL Limited | 2.64 Billion USD | 100.601% |
| Cellectis S.A. | -103.17 Million USD | 84.6% |